Susquehanna Fundamental Investments, LLC Immuno Gen, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $284,734 - $449,580	-59,944 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $294,448 - $386,536	-58,655 Reduced 49.46%	59,944 $340,000
Q2 2021 Aug 11, 2021	BUY	$5.79 - $8.6 $124,427 - $184,814	21,490 Added 22.13%	118,599 $782,000
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $318,699 - $659,794	86,135 Added 784.9%	97,109 $626,000
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $37,860 - $53,662	10,974 New	10,974 $40,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.